Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2025-12-26 @ 11:46 AM
Study NCT ID:
NCT05829616
Status:
UNKNOWN
Last Update Posted:
2023-04-25
First Post:
2023-03-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-17
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-23
First Submit QC Date:
None
Study First Post Date:
2023-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-13
Last Update Post Date:
2023-04-25
Last Update Post Date Type:
ACTUAL